By Suvarna Bhatt
San Francisco, May 1 (BioSpace) – Private Australian immunotherapy company, Replikun Biotech announces that Dr. Nick Samaras will be appointed Chairman of their Board of Directors.
Dr. Samaras has a Ph.D from the Walter & Eliza Hall Institute of Medical Research, University of Melbourne and an MBA from the School of Management, RMIT University.
Contact Suvarna Bhatt at sbhatt@biospace.com.
